Haldyn glass, trading at PE 18 compare to its peers trading more than 35 PE. The co. has upgraded its plant and value added service like printing on bottle and total solutions to its customers. The company’s customers include major pharmaceutical and brewery
companies like Glaxo Smithkline Pharma, Bajaj Corp, Hamdard, ADF,
Vadilal, Parle Agro, Zydus, Pfizer, Burroughs Welcome, Parke-Davis,
Raptakos Brett, Cipla, Hindustan Antibiotics, Wyeth, Novartis,
Associated Breweries and Distilleries, Mysore Breweries, UB Group,
Camlin, Bajaj Consumer Care, Champagne Indage, Tilaknagar Industries,
Empee Distilleries, Shiva Distilleries, Denischem, Amul, Smithkline
Beechem, Tablets India etc.The company’s products are mainly being supplied to the Spirits, Soft
Drink and Food Industries. The growth factor in Spirits is highest and
growing each year with double digit growth. With several Multi National
Companies arranging tie up with Indian Manufacturing units, the
company’s future growth prospects appear to be bright. Ban enforced by
the Central Government for use of PET bottles in Pharmaceutical Industry
is also giving the much needed boost to the Glass industry.
Looking to industry growth, the stock is attractive PE at 40-42 and worth to hold for medium to long term in portfolio.
Looking to industry growth, the stock is attractive PE at 40-42 and worth to hold for medium to long term in portfolio.
No comments:
Post a Comment